Rosette‐forming glioneuronal tumours are midline, FGFR1 ‐mutated tumours - Aix-Marseille Université Access content directly
Journal Articles Neuropathology and Applied Neurobiology Year : 2022

Rosette‐forming glioneuronal tumours are midline, FGFR1 ‐mutated tumours

Romain Appay
Franck Bielle
Philipp Sievers
  • Function : Author
Doriane Barets
  • Function : Author
Frédéric Fina
  • Function : Author
Jean Boutonnat
  • Function : Author
Clovis Adam
  • Function : Author
Guillaume Gauchotte
  • Function : Author
Catherine Godfraind
  • Function : Author
Benoît Lhermitte
  • Function : Author
Claude‐alain Maurage
  • Function : Author
David Meyronet
  • Function : Author
Karima Mokhtari
  • Function : Author
Audrey Rousseau
  • Function : Author
Arnault Tauziède-Espariat
  • Function : Author
Marie‐claire Tortel
  • Function : Author
Emmanuelle Uro-Coste
  • Function : Author
Fanny Burel-Vandenbos
Guillaume Chotard
  • Function : Author
Florian Pesce
  • Function : Author
Pascale Varlet
  • Function : Author
Carole Colin
No file

Dates and versions

hal-03982227 , version 1 (10-02-2023)

Identifiers

Cite

Romain Appay, Franck Bielle, Philipp Sievers, Doriane Barets, Frédéric Fina, et al.. Rosette‐forming glioneuronal tumours are midline, FGFR1 ‐mutated tumours. Neuropathology and Applied Neurobiology, 2022, 48 (5), ⟨10.1111/nan.12813⟩. ⟨hal-03982227⟩
10 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More